LLY

725.05

+0.04%↑

JNJ

180.79

+0.64%↑

ABBV

221.65

+0.42%↑

UNH

343.61

-0.16%↓

NVO

55.33

-0.49%↓

LLY

725.05

+0.04%↑

JNJ

180.79

+0.64%↑

ABBV

221.65

+0.42%↑

UNH

343.61

-0.16%↓

NVO

55.33

-0.49%↓

LLY

725.05

+0.04%↑

JNJ

180.79

+0.64%↑

ABBV

221.65

+0.42%↑

UNH

343.61

-0.16%↓

NVO

55.33

-0.49%↓

LLY

725.05

+0.04%↑

JNJ

180.79

+0.64%↑

ABBV

221.65

+0.42%↑

UNH

343.61

-0.16%↓

NVO

55.33

-0.49%↓

LLY

725.05

+0.04%↑

JNJ

180.79

+0.64%↑

ABBV

221.65

+0.42%↑

UNH

343.61

-0.16%↓

NVO

55.33

-0.49%↓

Search

Savara Inc

Closed

SectorHealthcare

3.51 1.45

Overview

Share price change

24h

Current

Min

3.51

Max

3.56

Key metrics

By Trading Economics

Income

-3.8M

-30M

Profit margin

-10,677.941

Employees

59

EBITDA

-1.9M

-30M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+150.85% upside

Dividends

By Dow Jones

Next Earnings

11 Nov 2025

Market Stats

By TradingEconomics

Market Cap

137M

603M

Previous open

2.06

Previous close

3.51

News Sentiment

By Acuity

83%

17%

347 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Savara Inc Chart

Past performance is not a reliable indicator of future results.

Related News

26 Sept 2025, 18:25 UTC

Major Market Movers

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

28 Sept 2025, 23:48 UTC

Market Talk

Nikkei May Rise After Friday's Stock Gains on Wall Street -- Market Talk

28 Sept 2025, 23:48 UTC

Market Talk

Global Equities Roundup: Market Talk

28 Sept 2025, 23:45 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Hopes -- Market Talk

28 Sept 2025, 23:34 UTC

Market Talk

Oil Falls on Likely Technical Correction -- Market Talk

27 Sept 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

26 Sept 2025, 21:56 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26 Sept 2025, 20:54 UTC

Earnings

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26 Sept 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26 Sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 Sept 2025, 20:27 UTC

Acquisitions, Mergers, Takeovers

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 Sept 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

26 Sept 2025, 19:54 UTC

Market Talk

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26 Sept 2025, 19:53 UTC

Acquisitions, Mergers, Takeovers

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 Sept 2025, 19:40 UTC

Earnings

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26 Sept 2025, 19:24 UTC

Market Talk

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26 Sept 2025, 19:17 UTC

Market Talk

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26 Sept 2025, 19:15 UTC

Market Talk

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26 Sept 2025, 19:03 UTC

Market Talk

Global Equities Roundup: Market Talk

26 Sept 2025, 19:03 UTC

Market Talk

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26 Sept 2025, 18:50 UTC

Market Talk
Earnings

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26 Sept 2025, 18:36 UTC

Market Talk

Silver Closes Out Week With Strong Surge -- Market Talk

26 Sept 2025, 18:02 UTC

Acquisitions, Mergers, Takeovers

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26 Sept 2025, 18:02 UTC

Acquisitions, Mergers, Takeovers

ING: Global Development Hasn't Received All Necessary Approvals >ING

26 Sept 2025, 18:02 UTC

Acquisitions, Mergers, Takeovers

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26 Sept 2025, 17:54 UTC

Market Talk

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26 Sept 2025, 16:56 UTC

Market Talk
Earnings

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26 Sept 2025, 16:41 UTC

Market Talk
Earnings

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26 Sept 2025, 16:26 UTC

Earnings

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26 Sept 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Savara Inc Forecast

Price Target

By TipRanks

150.85% upside

12 Months Forecast

Average 8.83 USD  150.85%

High 16 USD

Low 2 USD

Based on 6 Wall Street analysts offering 12 month price targets forSavara Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

2.76 / 2.84Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

347 / 371 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.
help-icon Live chat